What’s new at Capitainer – from global projects to local impact

From EU-funded collaborations to new colleagues and upcoming webinars, there’s plenty happening at Capitainer right now. Scroll down to see the latest highlights!

The UTI-Diag project is now online!

With the official kick-off in April this year, the project just recently launched a website and a set of social media accounts for communication of progress and results.
With funding support from the European Union through EDCTP3 and UK Research and Innovation, the project brings together 11 partners from Europe and Africa representing a groundbreaking multisectoral initiative designed to transform how we approach urinary tract infections globally.

The overall goals of the project are:

✅ Deliver affordable, rapid diagnostics

✅ Strengthen antimicrobial stewardship

✅ Advance equitable healthcare access

In the project, Capitainer is leading the work package “Non/minimally invasive sampling and processing”

Check out the project website and follow!
Website – UTI-Diag: Advanced UTI Diagnostic Solutions Initiative
LinkedIn: linkedin.com/company/utidiag
X (formerly Twitter): x.com/UTIDiag
YouTube: youtube.com/@UTI-Diag

Welcome Emelie!

As you know, every great adventure needs great people – and recently we welcomed another star to the Capitainer journey! 🌟

Emelie joins our Sales Operations team, bringing experience in international logistics and supply chain management from both the life science industry and fast-growing scale-ups. She will support daily operations and contribute to the continuous improvement of our sales processes🚀

Perhaps some reading for the weekend? 📖

Have you read our latest blog post on kidney health management? We explore how dried urine sampling could transform the field – from albumin to creatinine ratio (uACR) and beyond – enabling routine screening, chronic disease monitoring, and truly patient-centric care through simple at-home collection.

👉 Read the full post here

And who knows… could there be something on the Capitainer horizon? 👀

Capitainer in addiction research

Capitainer’s technology is increasingly being adopted in addiction research. We are proud to share that three different studies are now either ongoing or about to start, all using our microsampling solutions.

Among them is the COMIT study, focused on innovative digital interventions for substance use, and the PAC study, which investigates the relationship between controlled alcohol intake, blood alcohol concentration (BAC), and phosphatidylethanol (PEth) levels in blood.

The third study is the Spectrum study, which explores alcohol use disorder and its links to consumption patterns and treatment outcomes. The COMIT study is carried out by Linköping University while both PAC and Spectrum are carried out by the same group at the University of Gothenburg (Beroendemedicin | Göteborgs universitet).

Webinar: what’s next?

As we speak, our Marketing Manager Ingrid is at our lab, miQro, in Rhode Island visiting the team there – and of course planning the next Capitainer webinar! And guess what? Of course, it will be all about lead testing – what else!